223 related articles for article (PubMed ID: 26648966)
1. Cancer-Associated Stroke: The Bergen NORSTROKE Study.
Selvik HA; Thomassen L; Bjerkreim AT; Næss H
Cerebrovasc Dis Extra; 2015; 5(3):107-13. PubMed ID: 26648966
[TBL] [Abstract][Full Text] [Related]
2. Prior cancer in patients with ischemic stroke: the Bergen NORSTROKE study.
Selvik HA; Thomassen L; Logallo N; Næss H
J Stroke Cerebrovasc Dis; 2014; 23(5):919-25. PubMed ID: 24075585
[TBL] [Abstract][Full Text] [Related]
3. When to Screen Ischaemic Stroke Patients for Cancer.
Selvik HA; Bjerkreim AT; Thomassen L; Waje-Andreassen U; Naess H; Kvistad CE
Cerebrovasc Dis; 2018; 45(1-2):42-47. PubMed ID: 29402826
[TBL] [Abstract][Full Text] [Related]
4. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.
Bernard TJ; Fenton LZ; Apkon SD; Boada R; Wilkening GN; Wilkinson CC; Soep JB; Miyamoto SD; Tripputi M; Armstrong-Wells J; Benke TA; Manco-Johnson MJ; Goldenberg NA
J Pediatr; 2010 Apr; 156(4):651-6. PubMed ID: 20022340
[TBL] [Abstract][Full Text] [Related]
6. Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study.
Kvistad CE; Logallo N; Oygarden H; Thomassen L; Waje-Andreassen U; Naess H
Cerebrovasc Dis; 2013; 36(5-6):351-4. PubMed ID: 24192488
[TBL] [Abstract][Full Text] [Related]
7. Comparing withdrawal and non-withdrawal of life-sustaining treatment among patients who died from stroke.
Helvig E; Thomassen L; Waje-Andreassen U; Naess H
Vasc Health Risk Manag; 2015; 11():507-10. PubMed ID: 26366088
[TBL] [Abstract][Full Text] [Related]
8. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
9. Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series.
Álvarez-Pérez FJ; Verde I; Usón-Martín M; Figuerola-Roig A; Ballabriga-Planas J; Espino-Ibañez A
Eur Neurol; 2012; 68(4):209-13. PubMed ID: 23018798
[TBL] [Abstract][Full Text] [Related]
10. Predictors of occult cancer in acute ischemic stroke patients.
Cocho D; Gendre J; Boltes A; Espinosa J; Ricciardi AC; Pons J; Jimenez M; Otermin P
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1324-8. PubMed ID: 25881772
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Hypercoagulation Increases the Risk of Early Recurrent Stroke in Patients with Active Cancer.
Fujinami J; Ohara T; Kitani-Morii F; Tomii Y; Makita N; Yamada T; Kasai T; Nagakane Y; Nakagawa M; Mizuno T
Cerebrovasc Dis; 2018; 46(1-2):46-51. PubMed ID: 30064137
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.
Naess H; Nyland H; Idicula T; Waje-Andreassen U
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e435-40. PubMed ID: 23735372
[TBL] [Abstract][Full Text] [Related]
14. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
16. Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.
Ozaki S; Kurata M; Kumon Y; Matsumoto S; Tagawa M; Watanabe H; Ohue S; Higaki J; Ohnishi T
Hypertens Res; 2017 Jan; 40(1):61-66. PubMed ID: 27558929
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry.
Jia Q; Zhao X; Wang C; Wang Y; Yan Y; Li H; Zhong L; Liu L; Zheng H; Zhou Y; Wang Y
Stroke; 2011 Oct; 42(10):2758-62. PubMed ID: 21852614
[TBL] [Abstract][Full Text] [Related]
18. Stroke in patients with cancer: incidence and etiology.
Cestari DM; Weine DM; Panageas KS; Segal AZ; DeAngelis LM
Neurology; 2004 Jun; 62(11):2025-30. PubMed ID: 15184609
[TBL] [Abstract][Full Text] [Related]
19. Onset headache predicts good outcome in patients with first-ever ischemic stroke.
Chen PK; Chiu PY; Tsai IJ; Tseng HP; Chen JR; Yeh SJ; Yeh SJ; Sheu JJ; Chung CP; Wu MH; Hu CJ; Chang CY; Wei CY; Yip PK; Sung SF; Wang SJ; Hsu CY;
Stroke; 2013 Jul; 44(7):1852-8. PubMed ID: 23704109
[TBL] [Abstract][Full Text] [Related]
20. Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.
Hou H; Xiang X; Pan Y; Li H; Meng X; Wang Y
J Am Heart Assoc; 2021 Feb; 10(3):e018600. PubMed ID: 33412918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
